These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33248244)

  • 21. SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases.
    Wang Y; Lv Y; Liu Q
    Immun Inflamm Dis; 2020 Dec; 8(4):506-511. PubMed ID: 32725744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Stimulation With Recombinant Human Granulocyte Colony-Stimulating Factor for Coronavirus Disease 2019 (COVID-19)-Beware of Blind Spots.
    Meyer NJ; Lindell RB; Wherry EJ
    JAMA Intern Med; 2021 Jan; 181(1):78-80. PubMed ID: 32910155
    [No Abstract]   [Full Text] [Related]  

  • 23. Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
    Pati A; Padhi S; Suvankar S; Panda AK
    J Infect Dis; 2021 Jan; 223(1):175-178. PubMed ID: 33011811
    [No Abstract]   [Full Text] [Related]  

  • 24. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients.
    Tan C; Li S; Liang Y; Chen M; Liu J
    Braz J Infect Dis; 2020; 24(6):565-569. PubMed ID: 32950458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
    Harrison AG; Lin T; Wang P
    Trends Immunol; 2020 Dec; 41(12):1100-1115. PubMed ID: 33132005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review.
    Singh P; Tripathi MK; Yasir M; Khare R; Tripathi MK; Shrivastava R
    Plant Foods Hum Nutr; 2020 Dec; 75(4):458-466. PubMed ID: 33037564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
    Wang X; Zhou Y; Jiang N; Zhou Q; Ma WL
    Int J Infect Dis; 2020 Jun; 95():433-435. PubMed ID: 32353545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Principles and new perspectives in the vaccination against SARS-CoV-2 virus.
    Smetanová J; Střížová Z; Bartůňková J; Milota T
    Cas Lek Cesk; 2020; 159(7-8):298-302. PubMed ID: 33445936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
    Zhao T
    J Infect Dis; 2020 Sep; 222(8):1413. PubMed ID: 32726448
    [No Abstract]   [Full Text] [Related]  

  • 34. SARS-CoV-2: exposure to high external doses as determinants of higher viral loads and of increased risk for COVID-19. A systematic review of the literature.
    Calisti R
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):152-159. PubMed ID: 33412806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment.
    Jia R; Wang Y; Mao XY; Li SS; Xu N; Xiong JP; Shen L; Bai L; Liu W; Liu LJ; Ge FJ; Chen YL; Lin L; Xu JM
    Oncologist; 2015 Jun; 20(6):619-20. PubMed ID: 25926350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations on COVID-19 diagnostic targets.
    Wang R; Hozumi Y; Yin C; Wei GW
    Genomics; 2020 Nov; 112(6):5204-5213. PubMed ID: 32966857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of crash and burn patients with SARS-CoV-2 associated ARDS.
    Ghodsizad A; Grant AA; Mirsaeidi M; Sneij WC; Khalid L; Delazerda D; Auerbach JS; Alvarez RA; de Marchena EJ; Hare J; Guerra G; Vianna R; Loebe M
    J Card Surg; 2020 Sep; 35(9):2129-2130. PubMed ID: 32663349
    [No Abstract]   [Full Text] [Related]  

  • 38. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
    Tarasova O; Ivanov S; Filimonov DA; Poroikov V
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32604797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department.
    Nijhuis RHT; Russcher A; de Jong GJ; Jong E; Herder GJM; Remijn JA; Verweij SP
    J Clin Virol; 2020 Dec; 133():104655. PubMed ID: 33069846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.